Evidence lead: Bottom-seven record · Low appeal-filing share
Devoted Health: Only a small share of denials entered appeal
693 appeals correspond to 15.0% of the plan's denied requests. That is rank #34 of 37 for filing share. The ratio reports aggregate activity; it cannot reveal why an appeal was or was not filed, whether the underlying cases were comparable, or what happened outside the reporting window.
Bottom-seven record · Low appeal-filing share
Only a small share of denials entered appeal
693 appeals correspond to 15.0% of the plan's denied requests. That is rank #34 of 37 for filing share. The ratio reports aggregate activity; it cannot reveal why an appeal was or was not filed, whether the underlying cases were comparable, or what happened outside the reporting window.
Ranks twenty-six through thirty · Moderate request-volume cohort
A mid-lower authorization workload
This contract's 67,000 requests form a moderate comparison base within the table. Its request-volume rank is #26 of 37. Volume shows the denominator behind approvals and denials; it is not a measure of plan quality, membership, benefit breadth, price, or future coverage decisions.
Ranks eleven through fifteen · Upper-middle overturn cohort
Appeal overturns ran above most contracts
The observed overturn rate is 72.0%, in the upper-middle portion of the table. Its overturn-rate rank is #15 of 37. The denominator is filed appeals, not all authorization requests. The percentage therefore describes reviewed appeals and must not be read as an individual outcome forecast.
Ranks sixteen through twenty · Upper-middle reversal reach
Reversals covered an above-median share of denials
Overturned appeals represent 10.8% of all denials here, based on 499 reversals. The cross-contract rank is #16 of 37. This derived measure combines appeal filing and outcome, so it supplies scale context but does not identify clinical reasons, administrative errors, or coverage rules.
Ranks sixteen through twenty · Upper-middle denial cohort
Above the center of the denial-rate ordering
The recorded 6.9% denial rate falls in the upper-middle portion of the contract set. The exact rank is #20 of 37. This is aggregate prior-authorization activity for the reporting window, not a probability that a particular service, drug, or beneficiary request will be denied.